Chitosan oligosaccharide promotes osteoclast formation by stimulating the activation of MAPK and AKT signaling pathways

References

• Xia WS. Physiological activities of chitosan and its application in functional foods. J Chinese Inst Food Sci Technol. 2003.
   Google Scholar
• Zhang J, Xia W, Liu P, et al. Chitosan modification and pharmaceutical/biomedical applications. Marine Drugs. 2010;8(12):1962–1987. doi:10.3390/md8071962.
   PubMedGoogle Scholar
• Carvalho LC, Queda F, Santos CV, et al. Selective modification of chitin and chitosan: en route to tailored oligosaccharides. Chem Asian J. 2016 Dec 19;11(24):3468–3481. doi:10.1002/asia.201601041 . PubMed PMID: 27723949.
   PubMed Web of Science ®Google Scholar
• Shigemasa Y, Minami S. Applications of chitin and chitosan for biomaterials. Biotechnol Genet Eng Rev. 1996;13(1):383–420. doi:10.1080/02648725.1996.10647935.
   PubMed Web of Science ®Google Scholar
• Muxika A, Etxabide A, Uranga J, et al. Chitosan as a bioactive polymer: processing, properties and applications. Int J Biol Macromol. 2017;105(Pt 2):1358.10.1016/j.ijbiomac.2017.07.087
   PubMed Web of Science ®Google Scholar
• Tamara SE, Viktoria D, Inna K, et al. Marine compounds with therapeutic potential in gram-negative sepsis. Marine Drugs. 2013;11(6):2216–2229.
   PubMed Web of Science ®Google Scholar
• Cassano R, Gioia MLD, Mellace S, et al. Hemostatic gauze based on chitosan and hydroquinone: preparation, characterization and blood coagulation evaluation. J Mater Sci Mater Med. 2017;28(12):190.10.1007/s10856-017-6000-x
   PubMed Web of Science ®Google Scholar
• Hu L, Sun Y, Wu Y. Advances in chitosan-based drug delivery vehicles. Nanoscale. 2013;5(8):3103–3111.10.1039/c3nr00338 h
   PubMed Web of Science ®Google Scholar
• Martino AD, Sittinger M, Risbud MV. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials. 2005;26(30):5983–5990.10.1016/j.biomaterials.2005.03.016
   PubMed Web of Science ®Google Scholar
• Ahsan SM, Thomas M, Reddy KK, et al. Chitosan as biomaterial in drug delivery and tissue engineering. Int J Biol Macromol. 2017 Sep 1. doi:10.1016/j.ijbiomac.2017.08.140 . PubMed PMID: 28866015.
   Google Scholar
• Tan ML, Shao P, Friedhuber AM, et al. The potential role of free chitosan in bone trauma and bone cancer management. Biomaterials. 2014 Sep;35(27):7828–7838. doi:10.1016/j.biomaterials.2014.05.087 . PubMed PMID: 24947230.
   PubMed Web of Science ®Google Scholar
• Beenken KE, Smith JK, Skinner RA, et al. Chitosan coating to enhance the therapeutic efficacy of calcium sulfate-based antibiotic therapy in the treatment of chronic osteomyelitis. J Biomater Appl. 2014;29(4):514.10.1177/0885328214535452
   PubMed Web of Science ®Google Scholar
• Zou P, Yang X, Wang J, et al. Advances in characterisation and biological activities of chitosan and chitosan oligosaccharides. Food Chem. 2016 Jan 1;190:1174–1181. doi:10.1016/j.foodchem.2015.06.076 . PubMed PMID: 26213092.
   PubMed Web of Science ®Google Scholar
• Muanprasat C, Chatsudthipong V. Chitosan oligosaccharide: biological activities and potential therapeutic applications. Pharmacol Ther. 2017 Feb;170:80–97. doi:10.1016/j.pharmthera.2016.10.013 . PubMed PMID: 27773783.
   PubMed Web of Science ®Google Scholar
• Chen S, Jin G, Huang KM, et al. Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo. Sci Rep. 2015;5:12853.10.1038/srep12853
   PubMed Web of Science ®Google Scholar
• Tian B, Jiang T, Shao Z, et al. The prevention of titanium-particle-induced osteolysis by OA-14 through the suppression of the p38 signaling pathway and inhibition of osteoclastogenesis. Biomaterials. 2014;35(32):8937.10.1016/j.biomaterials.2014.06.055
   PubMed Web of Science ®Google Scholar
• Liu X, Qu X, Wu C, et al. The effect of enoxacin on osteoclastogenesis and reduction of titanium particle-induced osteolysis via suppression of JNK signaling pathway. Biomaterials. 2014;35(22):5721–5730.10.1016/j.biomaterials.2014.04.006
   PubMed Web of Science ®Google Scholar
• Xie Z, Yu H, Sun X, et al. A novel diterpenoid suppresses osteoclastogenesis and promotes osteogenesis by inhibiting Ifrd1‐ and IκBα‐mediated p65 nuclear translocation. J Bone Miner Res. 2017.
   Google Scholar
• Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337–342.10.1038/nature01658
   PubMed Web of Science ®Google Scholar
• Nakashima T, Hayashi M, Takayanagi H. New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab. 2012 Nov;23(11):582–590. doi:10.1016/j.tem.2012.05.005 . PubMed PMID: 22705116.
   PubMed Web of Science ®Google Scholar
• Li L, Sapkota M, Gao M, et al. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway. Eur J Pharmacol. 2017 Nov 15;815:202–209. doi:10.1016/j.ejphar.2017.09.015 . PubMed PMID: 28919027.
   PubMed Web of Science ®Google Scholar
• Kulkarni AR, Kulkarni VH, Keshavayya J, et al. Anti-microbial activity and film characterization of thiazolidinone derivatives of chitosan. Macromol Biosci. 2005;5(6):490–493.10.1002/(ISSN)1616-5195
   PubMed Web of Science ®Google Scholar
• Olaru AM, Marin L, Morariu S, et al. Biocompatible chitosan based hydrogels for potential application in local tumour therapy. Carbohyd Polym. 2017.
   PubMed Web of Science ®Google Scholar
• Huber D, Grzelak A, Baumann M, et al. Anti-inflammatory and anti-oxidant properties of laccase-synthesized phenolic-O-carboxymethyl chitosan hydrogels. New Biotechnol. 2017.
   PubMed Web of Science ®Google Scholar
• Ouyang Z, Zhai Z, Li H, et al. Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway. Biochem Pharmacol. 2014 Aug 1;90(3):276–287. doi:10.1016/j.bcp.2014.06.009 . PubMed PMID: 24950468.
   PubMed Web of Science ®Google Scholar
• Ae G, Zq W, Mg C, et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science (New York, NY). 1994;266(5184):443–448.
   Google Scholar
• Mansky KC, Sankar U, Han J, et al. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling. J Biol Chem. 2002;277(13):11077–11083.10.1074/jbc.M111696200
   PubMed Web of Science ®Google Scholar
• Gingery A, Bradley E, Shaw A, et al. Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival. J Cell Biochem. 2003;89(1):165.10.1002/jcb.10503
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Sudo T, Saito T, et al. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J Biol Chem. 2000;275(40):31155–31161.10.1074/jbc.M001229200
   PubMed Web of Science ®Google Scholar
• Sik-Won C, Kie-In P, Jeong-Tae Y, et al. Anti-osteoclastogenic activity of matairesinol via suppression of p38/ERK-NFATc1 signaling axis. Bmc Complement Alter Med. 2014;14(1):1–8.
   PubMedGoogle Scholar
• Kobayashi N, Kadono Y, Naito A, et al. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 2001;20(6):1271.10.1093/emboj/20.6.1271
   PubMed Web of Science ®Google Scholar
• Chapurlat RD, Palermo L, Ramsay P, et al. Risk of fracture among women who lose bone density during treatment with alendronate. Osteoporos Int. 2005;16(7):842–848.10.1007/s00198-004-1770-7
   PubMed Web of Science ®Google Scholar
• Monje P, Hernández-Losa J, Lyons RJ, et al. Regulation of the transcriptional activity of c-Fos by ERK. J Biol Chem. 2005;280(42):35081.10.1074/jbc.C500353200
   PubMed Web of Science ®Google Scholar
• Iotsova V, Caamaño J, Loy J, et al. Osteopetrosis in mice lacking NF-|[kappa]|B1 and NF-|[kappa]|B2. Nat Med. 1997;3(11):1285.10.1038/nm1197-1285
   PubMed Web of Science ®Google Scholar
• Franzoso G, Carlson L, Xing L, et al. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 1997;11(24):3482–3496.10.1101/gad.11.24.3482
   PubMed Web of Science ®Google Scholar
• Rochet N, Balaguer T, Boukhechba F, et al. Differentiation and activity of human preosteoclasts on chitosan enriched calcium phosphate cement. Biomaterials. 2009;30(26):4260.10.1016/j.biomaterials.2009.04.044
   PubMed Web of Science ®Google Scholar
• Jones GL, Motta A, Marshall MJ, et al. Osteoblast: osteoclast co-cultures on silk fibroin, chitosan and PLLA films. Biomaterials. 2009;30(29):5376–5384.10.1016/j.biomaterials.2009.07.028
   PubMed Web of Science ®Google Scholar
• Torres AL, Santos SG, Oliveira MI, et al. Fibrinogen promotes resorption of chitosan by human osteoclasts. Acta Biomater. 2013;9(5):6553–6562.10.1016/j.actbio.2013.01.015
   PubMed Web of Science ®Google Scholar